R. Darcy, B. J. Ravoo et al.
OH-3); 4.89 (d, 8H, J1,2 =3.1 Hz, H-1); 3.77 (m, 8H, H-3); 3.6 (m, 8H,
H-5); 3.05–3.32 (m, 16H, H-2, H-4); 2.7–2.85 (m, 16, H-6); 2.57 (t, 16H,
SCH2); 1.53 (m, 16H, SCH2CH2); 1.27 (brm, 144H, CH2); 0.87 (d, 24H,
CH3) ppm; 13C NMR (75 MHz, [D6]DMSO): d=105.9 (C-1), 88.7 (C-4),
76.6, 76.2, 75.5 (C-3, C-2, C-5), 37.4–22.0 (dodecyl), 26.0 (C-6), 14.0
(CH3) ppm; elemental analysis calcd (%) for C144H272O32S8 (2769.7): C
62.39, H 9.89, S 9.25; found: C 63.51, H 9.70, S 9.18; MALDI MS: m/z:
2792 [M+Na]+, 2808 [M+K]+.
(%): 3764 (39) [M22EO+Na]+, 3720 (62) [M21EO+Na]+, 3676 (87)
[M20EO+Na]+, 3632 (100) [M19EO+Na]+, 3588 (92) [M18EO+Na]+, 3544
(67) [M17EO+Na]+, 3500 (29) [M16EO+Na]+.
Hexakis [6-hexadecylthio-2-oligo(ethylene oxide)]-a-cyclodextrin 7a:
Compound 5a (4.0 g) was treated with ethylene carbonate to yield 7a
(4.3 g, 89%). 1H NMR (300 MHz, [D]CHCl3): d=5.05 (brs, 6H, H-1);
4.0–3.3 (m, H-3, H-5, H-2, H-4, OCH2CH2O); 3.00 (m, 12H, H-6); 2.60
(m, 12H, SCH2); 1.57 (m, 12H, CH2); 1.30 (brs, 156H, CH2); 0.88 (t,
18H, CH3) ppm; 13C NMR (75 MHz, [D]CHCl3): d=100.9 (C-1), 81.2 (C-
2, C-4), 71.0–72.5 (C-3, C-5, CH2O), 61.5 (CH2OH), 34.1 (C-6), 33.7
(CH2S), 32.0 (CH2), 29.8 (CH2)n, 29.7 (CH2), 29.5 (CH2), 29.4 (CH2), 29.2
(CH2), 22.7 (CH2), 14.1 (CH3) ppm; elemental analysis calcd (%) for
C156H300O36S6 (2941.4): C 63.64, H 10.27, S 6.53; found: C 61.22, H 9.75, S
6.10; MALDI MS: m/z (%): 3070 (24) [M15EO]+, 3027 (55) [M14EO]+, 2983
(86) [M13EO]+, 2940 (100) [M12EO]+, 2896 (90) [M11EO]+, 2853 (55)
[M10EO]+, 2808 (26) [M9EO]+.
Hexakis(6-hexadecylthio)-a-cyclodextrin 5a: Compound 2a (1.0 g) was
treated with hexadecanethiol to yield 5a (1.8 g, 74%). Alternatively, 3a
(6.5 g) was treated with hexadecanethiol to yield 5a (6.8 g, 58%).
1H NMR (300 MHz, [D6]DMSO): d=5.90 (s, 6H, OH-2); 5.84 (s, 6H,
OH-3); 4.89 (d, 6H, J1,2 =3.1 Hz, H-1); 3.77 (m, 6H, H-3); 3.6 (m, 6H,
H-5); 3.05–3.32 (m, 12H, H-2, H-4); 2.7–2.85 (m, 14H, H-6); 2.57 (t,
12H, SCH2); 1.53 (m, 12H, SCH2CH2); 1.27 (brs, 156H, 13ꢁCH2); 0.87
(d, 18H, CH3) ppm; 13C NMR (75 MHz, [D6]DMSO): d=102.9 (C-1),
86.7 (C-4), 74.8, 74.1, 73.5 (C-3, C-2, C-5), 60.2 (C-6), 37.4–22.0 (hexa-
decyl), 26.0 (C-6), 13.9 (CH3) ppm; elemental analysis calcd (%) for
C132H252O24S6 (2413.7): C 65.63, H 10.51, S 7.96; found: C 63.83, H 9.70, S
7.48; MALDI MS: m/z: 2437 [M+Na]+, 2451 [M+K]+.
Octakis [6-hexadecylthio-2-oligo(ethylene oxide)]-g -cyclodextrin 7c:
Compound 5c (0.75 g) was treated with ethylene carbonate to yield 7c
(0.75 g, 85%). 1H NMR (300 MHz, [D]CHCl3): d=5.05 (brs, 8H, H-1);
4.0–3.3 (m, H-3, H-5, H-2, H-4, OCH2CH2O); 3.00 (m, 16H, H-6); 2.60
(m, 16H, SCH2); 1.57 (m, 14H, CH2); 1.30 (brm, 208H, CH2); 0.88 (t,
24H, CH3) ppm; 13C NMR (75 MHz, [D]CHCl3): d=100.9 (C-1), 81.2 (C-
2, C-4), 71.0–72.5 (C-3, C-5, CH2O), 61.5 (CH2OH), 34.1 (C-6), 33.7
(CH2S), 32.0 (CH2), 29.8 (CH2)n, 29.7 (CH2), 29.5 (CH2), 29.4 (CH2), 29.2
(CH2), 22.7 (CH2), 14.1 (CH3) ppm; elemental analysis calcd (%) for
Octakis(6-hexadecylthio)-g-cyclodextrin 5c: Compound 2c (0.3 g) was
treated with hexadecanethiol to yield 5c (0.28 g, 43%). Alternatively, 3c
(0.75 g) was treated with hexadecanethiol to yield 5c (1.0 g, 76%).
1H NMR (300 MHz, [D6]DMSO): d=5.90 (s, 8H, OH-2); 5.84 (s, 8H,
OH-3); 4.89 (d, 8H, J1,2 =3.1 Hz, H-1); 3.77 (m, 8H, H-3); 3.6 (m, 8H,
H-5); 3.05–3.32 (m, 16H, H-2, H-4); 2.7–2.85 (m, 16H, H-6); 2.57 (t,
16H, SCH2); 1.53 (m, 16H, SCH2CH2); 1.27 (brm, 208H, CH2); 0.87 (d,
24H, CH3) ppm; 13C NMR (75 MHz, [D6]DMSO): d=105.9 (C-1), 88.7
(C-4), 76.6, 76.2, 75.5 (C-3, C-2, C-5), 37.4–22.0 (hexadecyl), 26.0 (C-6),
14.0 (CH3) ppm; elemental analysis calcd (%) for C176H336O32S8 (3218.2):
C 65.63, H 10.51, S 7.96; found: C 64.81, H 10.21, S 8.09; MALDI MS:
m/z: 3255 [M+K]+.
C
S
208H400O48S8 (3922.7): C 63.64, H 10.27, S 6.53; found: C 63.82, H 10.01,
6.48; MALDI MS: m/z (%): 4756 (67) [M35EO+Na]+, 4741 (75)
[M34EO+Na]+, 4696 (92) [M33EO+Na]+, 4652 (92) [M32EO+Na]+, 4607 (82)
[M31EO+Na]+, 4568 (77) [M30EO+Na]+, 4524 (65) [M29EO+Na]+.
Vesicle preparation: Vesicles of 6a–c and 7a–c were prepared by sonica-
tion or extrusion. Typically, amphiphilic cyclodextrin (several mg) in
chloroform (approximately 1 mL) was dried by rotary evaporation to
yield a thin film in a glass vial. Residual solvent was removed under high
vacuum. Water or buffer (1–5 mL, 10 mm phosphate or 2-[4-(2-hydroxy-
ethyl)-1-piperazinyl]ethanesulfonic acid (HEPES), pH 7.2) was added
and the sample solution was kept for 1 h at room temperature (6a–c) or
at 508C (7a–c). The resulting suspension was sonicated in a Bran-
sonic 1510 sonication bath for 1 h to give small unilamellar vesicles. Al-
General procedure for the preparation of amphiphilic cyclodextrins 6a–c
and 7a–c:[17] The appropriate alkyl thioether 4a–c or 5a–c (0.5–5.0 g),
K2CO3 (10% by weight of cyclodextrin), and ethylene carbonate
(50 equiv) were mixed in N,N,N’,N’-tetramethylurea (5–15 mL). The mix-
ture was stirred at 1508C for 4 h. The reaction was monitored by TLC
(CHCl3/MeOH/H2O 50:10:1, Rf =0 for 4a–c and 5a–c, Rf =0.6 for 6a–c
and 7a–c). The solvent was evaporated under high vacuum at 708C in a
bulb-to-bulb destillation unit. In large scale reactions (>1 g), the crude
product was stirred overnight in a solution of NaOMe (0.1m) in metha-
nol.[17] The crude product was purified by size-exclusion chromatography
(Sephadex LH-20, methanol). For further purification, 6c was crystallized
in methanol and 7c was eluted over a silica-gel column with a mixture of
chloroform and methanol (9:1).
ternatively, the suspension was repeatedly passed through
a poly-
carbonate membrane with 0.1 mm pore size in a LiposoFast extruder.
Vesicles of 6a–c were sonicated or extruded at room temperature, where-
as vesicles of 7a–c (with a melting temperature, Tm, estimated to be
around 488C)[6a] were sonicated or extruded at 508C. Reference vesicles
were prepared from C12EO3 (10 mg) that was dissolved in chloroform
(1 mL) and then dried by rotary evaporation for 3 h to give a thin film.
Water (2.5 mL) was added and the sample was sonicated below 208C for
30 min.
Hexakis [6-dodecylthio-2-oligo(ethylene oxide)]-a-cyclodextrin 6a: Com-
pound 4a (5.0 g) was treated with ethylene carbonate to yield 6a (4.9 g,
1
Transmission electron microscopy (TEM): Samples for TEM were pre-
pared on 200 mesh formvar-carbon-coated copper grids. A drop of cyclo-
dextrin solution (approximately 0.1 mgmLꢀ1) was left on the grid for
2 min then gently blotted with filter paper. The samples were stained
with a drop of 2% (w/w) uranyl acetate, left for 5 min, and blotted again.
The samples were investigated in a JEOL 2000 transmission electron mi-
croscope operating at 80 kV.
93%). H NMR (300 MHz, [D]CHCl3): d=5.05 (brs, 6, H-1); 4.0–3.4 (m,
H-3, H-5, H-2, H-4, OCH2CH2O); 3.00 (m, 12, H-6); 2.60 (m, 12H,
SCH2); 1.60 (m, 12H, CH2); 1.27 (brs, 108H, CH2); 0.89 (t, 18H,
CH3) ppm; 13C NMR (75 MHz, [D]CHCl3): d=100.7 (C-1), 81.0 (C-2, C-
4), 71.0–72.0 (C-3, C-5, CH2O), 61.2 (CH2OH), 33.4 (C-6), 33.4 (CH2S),
31.7 (CH2), 29.5 (CH2)n, 29.2 (CH2), 28.8 (CH2), 22.4 (CH2), 13.9
(CH3) ppm; elemental analysis calcd (%) for C132H254O36S6 (2607.6): C
60.75, H 9.81, S 7.37; found: C 59.45, H 9.75, S 7.42; MALDI MS: m/z
(%): 2851 (24) [M17EO+Na]+, 2807 (47) [M16EO+Na]+, 2762 (73)
[M15EO+Na]+, 2719 (100) [M14EO+Na]+, 2674 (100) [M13EO+Na]+, 2630
(71) [M12EO+Na]+, 2586 (36) [M11EO+Na]+.
Dynamic light scattering: Dynamic light-scattering measurements were
carried out at room temperature by using Malvern instrumentation. The
amphiphile concentration was approximately 0.2 mgmLꢀ1. The solutions
were filtered through 0.45 mm Gelman Acrodisk syringe filters prior to
light-scattering measurements. Size distributions were obtained from a
CONTIN analysis of the scattering data.
Octakis [6-dodecylthio-2-oligo(ethylene oxide)]-g-cyclodextrin 6c: Com-
pound 4c (100 mg) was treated with ethylene carbonate to yield 6c
(90 mg, 69%). 1H NMR (300 MHz, [D]CHCl3): d=5.05 (brs, 8H, H-1);
4.0–3.4 (m, H-3, H-5, H-2, H-4, OCH2CH2O); 3.00 (m, 16H, H-6); 2.60
(m, 16H, SCH2); 1.60 (m, 16H, CH2); 1.27 (brs, 144H, CH2); 0.89 (t,
24H, CH3) ppm; 13C NMR (75 MHz, [D]CHCl3): d=100.7 (C-1), 81.0 (C-
2, C-4), 71.0–72.0 (C-3, C-5, CH2O), 61.2 (CH2OH), 33.4 (C-6), 33.4
(CH2S), 31.7 (CH2), 29.5 (CH2)n, 29.2 (CH2), 28.8 (CH2), 22.4 (CH2), 13.9
(CH3) ppm; elemental analysis calcd (%) for C176H336O48S8 (3474.2): C
60.80, H 9.74, S 7.38; found: C 61.74, H 9.68, S 8.11; MALDI MS: m/z
Dye encapsulation: A 10 mm solution of carboxyfluorescein was prepared
in 10 mm HEPES buffer solution (pH 7.2). Cyclodextrin vesicles were
prepared by dissolving the appropriate cyclodextrin 6a–c or 7a–c in
chloroform and then evaporating the solvent to form a thin film. The car-
boxyfluorescein solution (1 mL) was added and the cyclodextrin film was
hydrated for 1 h. Next, the sample was shaken vigorously and sonicated
for 1 h at 508C. Cyclodextrin concentrations ranging from 0.5–
20 mgmLꢀ1 were evaluated, although little entrapment of dye molecules
1178
ꢂ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2005, 11, 1171 – 1180